Normobaric pulmonary oxygen toxicity : experimental studies on the mechanism of the protective role of endotoxin and the role of surfactant. by Klein, J. (Jan)
NORMOBARIC PULMONARY OXYGEN TOXICITY 
experimental studies on the mechanism of 
the protective role of endotoxin 
and the role of surfactant 

NORMOBARIC PULMONARY OXYGEN TOXICITY 
experimental studies on the mechanism of 
the protective role of endotoxin 
and the role of surfactant 
NORMOBARE PULMONALE ZUURSTOF TOXICITEIT 
experimentele studies naar het mechanisme van 
de beschermende werking van endotoxine 
en de rol van surfactant 
PROEFSCHRIFT 
ter verkrijging van de graad van doctor 
aan de Erasmus Universiteit Rotterdam 
op gezag van de rector magnificus 
Prof. Dr. C.J. Rijnvos 
en volgens besluit van het college van dekanen. 
De openbare verdediging zal plaats vinden op 
woensdag 13 maart 1991 om 15.15 uur 
door 
Jan Klein 
geboren te Schiedam 
1991 
Offsetdrukkerij Haveka B.V., 
Alblasserdam 
PROMOTIECOMMISSIE: 
Promotor 
Overige leden 
: Prof. Dr. W. Erdmann 
: Prof. Dr. H.A. Bruining 
: Prof. Dr. B. Lachmann 
: Prof. Dr. C. Hilvering 
De uitgave van dit proefschrift werd mede mogelijk gemaakt dankzij financiele steun 
van: 
de Stichting Dr. A.A. van Puyvelde Fonds 
Ill nv W.A. Hoek's Machine- en Zuurstoffabriek 
hoekbos 
Chapter 1 
Chapter 2 
Chapter 3 
Chapter 4 
Chapter 5 
Chapter 6 
PREFACE 
ABBREVIATIONS 
CONTENTS 
REVIEW OF THE LITERATURE 
Normobaric pulmonary oxygen toxicity. 
Klein J. 
ORIGINAL STUDIES 
1 
3 
5 
Endotoxin protection against oxygen toxicity 35 
and its reversal by acetylsalicylic acid. 
Klein J, Trouwborst A, Salt PJ. 
Cellular and eicosanoid composition of 43 
broncho-alveolar lavage fluid in endotoxin 
protection against pulmonary oxygen toxicity. 
Klein J, Zijlstra FJ, Vincent JE, van Strik R, 
Tak CJAM, van Schalwijk WP. 
Endotoxin protection against pulmonary oxygen 55 
toxicity and its reversal by acetylsalicylic acid: 
Role of eicosanoid production by broncho-alveolar 
lavage cells. 
Klein J, Vermeer MA, Zijlstra FJ, Vincent JE, 
Tak CJAM. 
Surfactant in pulmonary oxygen toxicity. 63 
Armbruster S, Klein J, Stouten EM, Erdmann W, 
Lachmann B. 
Acute respiratory failure induced by tracheal 71 
instillation of xanthine oxidase, its prevention 
and therapy by exogenous surfactant instillation. 
Lachmann B, Saugstad OD, Klein J, Erdmann W. 
SUMMARY AND CONCLUSIONS 
SAMENVATIING EN CONCLUSIES 
ACKNOWLEDGEMENTS 
CURRICULUM VITAE 
LIST OF PUBLICATIONS 
ii 
79 
81 
83 
85 
87 
PREFACE 
Administration of above-ambient oxygen tensions, necessary for treatment of severe 
hypoxemia caused by respiratory failure or acute lung injury, is potentially toxic for 
the lungs. This thesis is based on six articles dealing with this topic: one review article 
and five articles describing original experimental work. 
The literature review (Chapter 1) aims to put the five original studies in a 
broader perspective. Chapters 2, 3 and 4 are based on studies to analyze endotoxin's 
mechanism of action: endotoxin is reported, in rats, to be the most effective 
pharmacologic agent for increasing oxygen tolerance. 
Working under the supervision of Professor Dr. B. Lachmann, one of the 
leading experts on the pulmonary surfactant system, Chapters 5 and 6 investigate the 
role of surfa.ctant in pulmonary oxygen toxicity. 
Although the five original studies have their own Discussion and Conclusion 
sections, some aspects are elaborated upon in the literature review (Chapter 1) and, 
consequently, there is no separate Discussion chapter in this thesis. 
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CHAPTER 1 
NORMOBARIC PULMONARY OXYGEN TOXICITY 
This review article has been published before in: Anesth Analgesia 1990; 
70: 195-207 
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NORMOBARIC PULMONARY OXYGEN TOXICITY 
Jan Klein 
Department of Anesthesiology, Erasmus University Rotterdam, The Netherlands. 
INTRODUCTION 
At the time of the discovery of oxygen (02) Joseph Priestley speculated that it might 
prove of benefit in the treatment of some disease. At the same time he warned that the 
effects of 0 2 might not be uniformly beneficial: "From the greater strength and vivacity of 
the flame of a candle, in this pure air, it may be conjectured, that it might be peculiarly 
salutary to the lungs in certain morbid cases, when the common air would not be sufficient 
to carry off the phlogistic putrid effluvium fast enough. But, perhaps, we may also infer from 
these experiments, that though pure dephlogisted air might be very useful as a medicine, it 
might not be so proper for us in the usual healthy state of the body: for, as a candle burns 
out much faster in dephlogisticated than in common air, so we might, as may be said, live 
out too fast, and the animal powers be too soon exhausted in this pure ldnd of air. A 
moralist, at least, may say, that the air which nature has provided for us is as good as we 
deserve." [1] 
The classic nineteenth-century experiments of Paul Bert and Lorraine Smith 
proved that 0 2 in high concentration was indeed toxic to healthy mammalian lungs 
[2,3]. Bert demonstrated that it was the increase in partial pressure rather than 
concentration of 0 2 in the inspired atmosphere that was responsible for these 
deleterious effects. In recent years, a biochemical mechanism involving cellular 
production of partially reduced metabolites of 0 2 has been proposed as a basis for 0 2 
toxicity. The importance of enzymatic and other intracellular antioxidant defenses 
against pulmonary 0 2 toxicity is now appreciated. Experimental animal models of 
increased 0 2 tolerance have been extensively investigated but, as yet, there is no 
clinically useful means of reducing or preventing 0 2-induced lung injury in humans. 
Although this review article presents information on the clinical manifestations, 
pathology, mechanism and prevention of pulmonary 0 2 toxicity, recent developments 
concerning the mechanisms and prevention of hyperoxic damage in animal models will 
be emphasized because an increased understanding of these mechanisms may lead 
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to a more rational basis for the clinical use of 0 2 and the development of therapeutic 
measures effective in preventing or decreasing the effects of 0 2 toxicity. Data 
presented here on mechanisms of hyperoxic injury and protection are obtained from 
experiments done at normobaric conditions and elevated partial pressures of 0 2 • The 
reader is also referred to other reviews [4,5,6,7,8,9] where certain aspects of the 
subject may be covered in more detail. 
CLINICAL MANIFESTATIONS 
With exposure to hyperoxia at 1 atmosphere (atm) of pressure, the lung is the organ 
most severely damaged because pulmonary tissue P02 is the highest in the body. As 
pulmonary tissue P02 is directly determined by the alveolar P02 [10], arterial 
hypoxemia does not delay the development of pulmonary 0 2 toxicity at 1 atm of 
pressure [11]. Exposure to 0 2 at a partial pressure in excess of 2 atm of pressure also 
damages the central nervous system and may result in convulsions (the Paul Bert 
effect) due to sharply increased brain tissue p02 [10]. The rate at which 0 2 toxicity 
develops is directly related to the partial pressure of inspired 0 2• Until the Apollo fire 
of 1967 American astronauts breathed 100% 0 2 at a pressure of one-third of an 
atmosphere without showing any sign of pulmonary 0 2 toxicity. Hence, a high 
concentration of 0 2 may be less damaging at high altitude where the atmospheric 
pressure is reduced than is the same concentration at normobaric pressure [10]. 
The precise concentration of 0 2 that is toxic to humans has, for obvious 
reasons, been difficult to establish. Most data regarding the tolerable limits of 0 2 
breathing have been obtained from normal, healthy, young subjects. Thus, the effects 
of underlying disease and other factors such as age, nutritional status, endocrinologic 
status and the history of previous exposures to oxidants or other substances that may 
alter protective mechanisms against 0 2 toxicity are largely unknown. 
The onset of 0 2 toxicity may occur after an asymptomatic period, during which 
no physiologic changes are detectable. In nine young men who breathed 100% 0 2 for 
6-12 h, no abnormality could be detected in the alveolar-arterial 0 2 gradient, 
pulmonary-artery pressure, total pulmonary resistance, cardiac output or pulmonary 
extravascular water volume; in addition, there were no symptoms and no x-ray 
changes [12]. 
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In conscious subjects, the earliest manifestations of 0 2 toxicity are symptoms 
of tracheobronchial irritation like cough and substernal discomfort. The onset of 
symptoms of tracheobronchial irritation, roughly 4-22 h after the start of 0 2 breathing 
[13], parallels the occurrence of tracheitis and decreased tracheal clearance of mucus 
[14]. The symptoms of this 0 2-induced tracheobronchitis precede changes in 
pulmonary function tests, but the rate of development of these symptoms is so variable 
as to be a poor index of 0 2 tolerance. 
The most widely applied index of 0 2 toxicity in humans has been the vital 
capacity (VC), as early respiratory physiologists reported that subjects who breathed 
90%-100% 0 2 for 25-30 h had a decreased VC [13, 15]. In 1970 it was suggested that 
decreases in VC could be used to predict the onset, rate of development, and degree 
of severity of the toxic process in the lung caused by 0 2 exposure [16]. Subsequently, 
a mathematical description was developed [17] and named the "unit pulmonary toxicity 
dose". The unit pulmonary toxicity dose is still used as a guideline for 0 2 exposures by 
the U.S. Navy [18] and others [19,20]. Recently, however, the available data set was 
updated and a quantitative statistical analysis was performed to evaluate VC as an 
index of pulmonary 0 2 toxicity [21]. As previously noted by others [4,22], it showed 
that a decrease in VC is not an ideal index of 0 2 toxicity development. The VC 
measurement requires a trained subject, is effort-dependent and does not take into 
account the recovery periods as during intermittent exposure; moreover the response 
varies between individuals. As the index is based on the response of an individual of 
median susceptibility, more susceptible individuals would be at increased risk. 
In four healthy subjects, decreases in vital capacity were followed by small 
decreases in both static compliance and carbon monoxide diffusing capacity after 
breathing 0.98 atm of 0 2 for 48 h [15]. 
Pulmonary physiologic changes observed and reproduced in normal subjects 
exposed to 0 2 under experimental conditions may be obscured in the clinical setting. 
For example, patients exposed to 100% 0 2 for 21-44 h, compared with a control group 
exposed to less than 42% 0 2, had no detectable physiologic alterations following 
cardiac surgery [23]. Similarly, there was no evidence of pulmonary 0 2 toxicity, judged 
by respiratory function, in 41 patients having high-frequency jet ventilation of the lungs 
with at least 80% 0 2 for up to 12 days [24]. On the other hand, increased ratios of 
dead space to tidal volume and increased arteriovenous shunting have been reported 
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in patients with irreversible brain damage after ventilation with 100% 0 2 for 40 h [25]. 
However, the patients in this study received steroid therapy which may have affected 
the outcome. 
Although physiologic changes attributable to 0 2 breathing include decreases 
in VC, pulmonary compliance, and diffusing capacity, together with increases in 
arteriovenous shunting and ratio of dead space to tidal volume, early detection of 0 2 
toxicity requires more sensitive and specific tests. 
Using a bronchoalveolar lavage (BAL) technique in volunteers exposed to 
more than 95% 0 2 for 17 h, a significant alveolar-capillary leak expressed by the 
presence of increased plasma albumin and transferrin in lavage fluid was detected 
[26]. Similarly, increases of albumin in BAL fluid occurred in a dose-dependent manner 
in subjects inhaling 30-50% 0 2 for a mean of 45 h [27]. In the same study, clearance 
of inhaled technetium-labeled diethylenetriamine pentaacetate, a measure to assess 
lung epithelial permeability, was increased in subjects inhaling 50%02 • Quantitation of 
hydrocarbons such as pentane or ethane in expired alveolar gas is another direction 
in the development of possible indices of early oxidant damage. Because ethane and 
pentane are volatile hydrocarbons formed during free-radical induced lipid peroxidation, 
the presence of these gases indicates ongoing free radical formation in lung tissue 
[28]. Although in humans pentane production increases within 30-120 minutes of 
breathing 100% 0 2 [29], a dose relationship between inspired 0 2 concentration and 
ethane or pentane excretion is not yet established. In the future, it may be possible to 
develop a metabolic index for detection of hyperoxic pulmonary damage. The fact that 
the lungs' ability to metabolize biogenic amines, polypeptides, and prostaglandins 
[30,31 ,32] decreases soon after hyperoxic exposure might also be used to develop an 
"early warning" test of 0 2 toxicity. To date, use of the tests described above to detect 
pulmonary 0 2 toxicity in the clinical setting in an early phase has been limited for 
reasons including lack of specificity, problems with reproducibility and the need for 
sophisticated equipment. 
The above studies, however, do indicate that although early (reversible) 
physiologic, anatomic and biochemical changes can be detected after short exposure 
to hyperoxia using sensitive tests, humans can tolerate 100% 0 2 at sea level for 24-
48 h without serious pulmonary injury. Pulmonary damage results only with longer 
periods of exposure in normal subjects (but pulmonary tolerance to hyperoxia may be 
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altered by the underlying disease and other physiologic factors). Inspired 0 2 in 
concentrations of 50-100% over long periods of time carries a risk of lung damage, 
and the duration of exposure required to produce damage seems to be proportional 
to the concentration of inspired 0 2• The "safe" level of inspired 0 2 is not established, 
but we know that less than 50% 0 2 can be tolerated for extended periods of time 
without serious deleterious effects [4]. 
PATHOLOGY OF PULMONARY OXYGEN TOXICITY 
Most studies of pulmonary 0 2 toxicity, including ultrastructural morphometry, have 
been conducted in experimental animals. Few studies have been performed in human 
subjects; those that have been done have typically been done at autopsy after severe 
illnesses requiring high concentrations of 0 2 (usually delivered by mechanical 
ventilation). Consequently, although the details and time- course of pulmonary 0 2 
toxicity are well documented in experimental animals, only the end stages of 0 2 toxicity 
have been studied in humans. However, the sequence of morphologic changes that 
occurs in the lungs in response to pulmonary 0 2 toxicity seems to be quite similar in 
different animal species [4,33,34,35,36] and humans [37], but the duration and relative 
severity of each phase of the process show species variability. 
In most species, exposure to 100% 0 2 at 1 atm for 24-72 his associated with 
an initial phase of injury during which no significant evidence of morphologic injury is 
apparent. This phase is characterized by augmentation in the production rates of 
partially reduced 0 2 species [38] due to increased intracellular metabolism of 0 2 [39]. 
These free radicals are associated with alterations in cell metabolism that are not 
initially associated with changes in lung structure or ultrastructure. 
The earliest morphologic changes seen in the inflammatory phase involve 
subtle changes in endothelial cell structure, which result in pericapillary accumulation 
of fluid [33,37,40]. This stage of lung injury is associated with, or rapidly followed by, 
accumulation of thrombocytes, macrophages and neutrophils in the lung and the 
release of soluble mediators of inflammation [40,41,42,43]. 
After exposure of rats to 0 2 for 36 h neutrophils are rapidly recruited to the lung 
[43], and after 48 h, the volume of platelets retained in the pulmonary capillary bed 
almost doubles [41]. The appearance of neutrophils in the lung is associated with a 
rapid increase in the extent of morphologic lung injury [33,40]. Neutrophils probably 
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initiate the final stage of lethal pulmonary 0 2 toxicity by releasing further mediators of 
inflammation and, once activated, by producing toxic 0 2 species via oxidases on their 
plasma membranes [7,44]. Recently, it was suggested that one of these mediators, 
leukotoxin [9,10-epoxy-12-octadecenoate), plays an important role in the genesis of 
acute edematous lung damage in pulmonary 0 2 toxicity [45]. However, the exact role 
of the neutrophil as a primary mediator of hyperoxic lung injury is under debate. 
Depletion of neutrophils decreases the toxic effects of hyperoxia [46], but neutropenia 
induced in rabbits by the administration of nitrogen mustard does not prevent 
development of lung microvascular injury and pulmonary edema caused by exposure 
to hyperoxia [47]. Moreover, the presence of pre-existing lung damage with 
accumulation of neutrophils in the lung is generally associated with decreased rather 
than increased sensitivity to 0 2 toxicity. Examples include increased 0 2 tolerance in 
animals following preexposure to sublethal doses of 0 2 [33] or pretreatment with 
Bacille de Calmetter et Guetin (BCG) [48], endotoxin [49], oleic acid [50], phosgene 
[51] or a-naphthylthiourea [52]. These observations suggest that the neutrophil may 
contribute to but is not essential for the development of pulmonary 0 2 toxicity. 
The contribution of alveolar macrophages to pathologic effects in the lung is 
not clear. Oxygen in vivo appears to increase the number of macrophages in sections 
of rat lung but may not increase the number of cells obtainable with standard methods 
of lung lavage [53]. It is suggested that the macrophage is responsible for the influx 
of neutrophils into the lung by the release of chemotactic factors under hyperoxia [54]. 
Bacterial clearance in animal lungs in vivo decreases after exposure of animals to 
1 00% 0 2 [55]. Although bactericidal dysfunction of alveolar macrophages of neonatal 
rabbits exposed to hyperoxia has been reported [56,57], phagocytotic ability of 
pulmonary macrophages isolated from adult rats exposed to hyperoxia is normal [58], 
and the impaired bacterial clearance seen may be due to impaired mucociliary 
clearance [14]. Production of factors such as 0 2 radicals and eicosanoids by alveolar 
macrophages probably contributes to the pathology of lung damage in hyperoxia 
[59,60], but such an effect has not yet been shown directly. 
In the final phase, overt destruction of the capillary endothelium takes place. 
In rats exposed to lethal hyperoxia approximately 50% of capillary endothelial cells are 
destroyed in the few hours preceding the death of the animal [33]. However, this 
destruction of endothelial cells does not result in overt lung edema; a pleural effusion, 
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nearly equal in volume to the total lung capacity, and associated plasma volume 
depletion leading to respiratory or perhaps cardiovascular failure probably constitute 
the immediate cause of death in 0 2-poisoned rats [61,62,63,64]. Although the 
mechanism of this effusion deserves further study, the pleural effusion is the hallmark 
of 0 2 toxicity in the rat. 
At time of death in rats exposed to a lethal dose high concentration of 0 2 there 
is no significant change in the number of type 1 or type 2 alveolar epithelial cells, even 
though some ultrastructural changes occur, including ruffling of the membranes of 
alveolar type 1 cells and blunting of the microvilli on alveolar type 2 cells. A significant 
epithelial cell proliferative response or frank epithelial cell destruction has not been 
documented [33]. 
In primates, including humans, there appears to be proportionally greater injury 
to the alveolar epithelium during the destructive phase of 0 2 toxicity. In monkeys, the 
alveolar type 1 epithelium is almost completely destroyed after 4 days in 100% 0 2 • 
Hyperplasia of type 2 alveolar epithelial cells leads to almost total replacement of the 
alveolar epithelial lining with type 2 cells by the seventh day of exposure [35,40]. 
With discontinuation of exposure to hyperoxia, or during chronic exposure to 
sublethal hyperoxia, at least three events may develop as a result of the exposure. The 
first is the proliferation of type 2 alveolar cells that appears to constitute a restructuring 
of the alveoli of the lung. The second is a fibroblastic proliferation that may lead to an 
interstitial fibrosis, one that does not seem to have any utility in recovery and may 
simply be a manifestation of the aberrant proliferation of a cell type (the fibroblast) that 
is relatively insensitive to hyperoxia [33,36]. The third event is the development of 
pulmonary hypertension with major restructuring of the walls of large and small 
pulmonary arteries. Obliterative and restrictive rather than constrictive changes of the 
precapillary alveolar unit due to fibrosis and extension of the muscle in the 
microcirculation appear to be the basis for pulmonary hypertension induced by 
hyperoxia [65,66]. 
IN VITRO MODEL SYSTEMS 
In cell cultures individual cells exposed to hyperoxia can be damaged without 
interaction with other cells. This is most extensively demonstrated in endothelial cells. 
Aortic endothelial cells show evidence of impaired uptake of serotonin after 24 h of 
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exposure to 95% 0 2 [67], possibly due to decreased fluidity of the plasma membranes 
of these cells [68]. Although endothelial cells show morphologic changes within 24 h 
of exposure to 80% 0 2 [69], increased albumin permeability of cultured endothelial 
monolayers becomes detectable only after exposure to 95% 0 2 for 3 days [70]. 
In addition to cell cultures, organ cultures and lung explants have been used 
to evaluate the effects of 0 2 on the lung. Ciliary activity ceases in organ cultures of 
tracheal epithelium after 2-6 days of exposure to 60-80% 0 2 [71]. The exposure of 
tissue slices of rat lungs to hyperoxia results in a degradation of collagen [72]. 
Damage due to hyperoxia has also been reported in explants of parenchymal tissues 
from rat and rabbit lung [71 ,73]. Release of chromium 51 indicator from labeled lung 
tissue in culture showed that significant cell damage occurs within 18 h of exposure 
to 95%02 • 
A third in vitro model, the perfused lung has proven to be a sensitive model for 
detection of early functional damage to the pulmonary alveolar endothelium. Hyperoxia 
impairs the ability of pulmonary capillary endothelium in the perfused lung to remove 
various compounds, including serotonin and prostaglandins, from the pulmonary 
circulation [30,74,75]. 
MECHANISMS OF PULMONARY OXYGEN TOXICITY 
BIOCHEMISTRY OF OXYGEN TOXICITY 
The mechanism of 0 2 toxicity at the molecular level is now generally attributed to 0 2 
free-radical reactions with cellular components. Oxygen free radicals are highly reactive 
0 2 metabolites which have an unpaired orbital electron. The so-called "free radical 
theory of 0 2 toxicity" attributes the damaging effects of hyperoxia to these highly 
reactive metabolites of molecular 0 2 • These 0 2 free radicals are products of normal 
cellular oxidation-reduction processes. Under conditions of hyperoxia, their production 
increases markedly. The sources of 0 2 free radicals in hyperoxia are unknown but may 
be the accelerated oxidative processes in pulmonary parenchymal cells and 
phagocytes [38]. The enzyme xanthine oxidase, present in endothelial cells, has also 
been implicated as a source of toxic 0 2 metabolites during hyperoxia [76, 77]. 
The 0 2 molecule is normally susceptible to univalent reduction reactions in the 
cell to form a superoxide anion (02-) and hydrogen peroxide (H20 2) [39,78]. Although 
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it is likely that both the superoxide anion and hydrogen peroxide have direct toxic 
effects, they interact to produce even more dangerous species [79]. Figure 1 shows 
the Fenton reaction, which is catalyzed by metals, particularly ferrous iron, and which 
results in the formation of the harmless hydroxyl ion together with two extremely 
reactive species, the hydroxyl free radical (OH") and singlet 0 2 C02]. Although all 0 2 
radicals are capable of various toxic activities, including lipid peroxidation, 
depolymerisation of mucopolysaccarides, protein sulfhydryl oxidation, cross linking that 
can lead to enzyme inactivation, and nucleic acid damage, it seems likely that the 
hydroxyl free radical and singlet 0 2 are mainly responsible for the toxic effects of 0 2 
[80]. 
Much evidence has recently appeared concerning endogenous defense 
systems evolved by organisms to protect their biologic integrity from destruction by 
free radicals. As 0 2 free radicals are products of normal cellular oxidative processes, 
a multilayered biochemical defense system exists that protects organisms against 
excessive free radical damage (Fig. 1 ). 
r---------------------------------~ 
~ Lipid, protein, DNA reactions 
Toxic products of oxygen reduction 
02- OH • ,02 H202 
1 -~~ction ~ Quenhing reactions 
~~~c ~ ""~·r-_____ c_ru_a_la_se ______ ~ 
Superoxide ' 
02+HP2 HP+02 
dis mutase 
Glutathione peroxidase 
~
GSH Gl t th· GSSG 
Fig. 1: Scheme of free radical reactions and defense systems. 
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These biochemical defenses, which probably began evolving as soon as the first 
photosynthetic organisms began discharging 0 2 into the atmosphere, an event that 
can be dated to about 2 billion years ago [81], include both complex enzyme systems 
and low-molecular-weight free radical scavengers and are a prerequisite for aerobic 
life. Prototypes of these antioxidant enzymes are the metalloproteins, termed 
superoxide dysmutases (SODs), which neutralize superoxide by conversion to 
hydrogen peroxide [82]. Two enzymes subsequently guard against damage from 
hydrogen peroxide: catalase and glutathione peroxidase, both of which are capable 
of degradating intracellular hydrogen peroxide to water; glutathione peroxidase has a 
more general action and catalyzes the reduction of many hydroperoxides. 
The cytoplasmatic enzyme glutathione reductase participates in antioxidant 
defense by reforming reduced glutathione to glutathione. Glutathione, a preferential 
substrate for many oxidizing agents, is of primary importance sparing protein sulfhydryl 
(SH) groups from oxidation. 
The low-molecular-weight free radical scavengers include a-tocopherol, 
ascorbate and B-carotene, a variety of molecules that preferentially partition into 
membranes and function by reducing lipophilic free-radical species to less toxic forms. 
Any molecule that reacts with a free radical can be termed "scavenger"; thus cell 
components such as sugars, unsaturated amino acids, sulfur-containing amino acids, 
and unsaturated fatty acids can also scavenge free radicals. 
ROLE OF ARACHIDONIC ACID METABOLITES 
Arachidonic acid metabolites have biologic properties that can mimic the pulmonary 
changes produced by hyperoxic exposure. They have potent vasoactive, 
bronchoactive, and chemoattractant properties, and can increase . vascular 
permeability; all of these are features of hyperoxic lung injury. 
Mounting evidence suggests that reactive 0 2 metabolites can initiate the 
release and metabolism of arachidonic acid [60,83,84,85]. Increases in levels of 
cyclooxygenase as well as lipoxygenase pathway products in BAL fluid have been 
associated with hyperoxic lung injury [49,86,87,88], but the administration of a 
cyclooxygenase inhibitor to block the synthesis of prostaglandins does not result in a 
decrease but rather an increase in hyperoxic lung injury [87]. The early increases in 
prostaglandin levels in BAL fluid that have been documented [ 49,86,87], therefore, may 
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rather reflect an overall increase in arachidonic acid metabolism, with the increase in 
lipoxygenase pathway products being at least as important or, perhaps, having a more 
primary role in mediating the hyperoxic lung injury. Recent reports show reduced 
mortality, inhibition of neutrophil influx and a reduction in the increase of BAL 
leukotriene 84 levels in a rat hyperoxia model after treatment with the lipoxygenase 
inhibitor AA861 [89], and attenuation of rat and rabbit lung injury induced by hydrogen 
peroxide or an oxidant lipid peroxide using various leukotriene antagonists and 
inhibitors [83,90]. A primary etiologic role for lipoxygenase pathway products would 
provide an explanation for the seemingly contradictory results of studies in which the 
use of a cyclooxygenase inhibitor resulted in exacerbation of prostaglandin-associated 
lung injury [87,91]. Blockade of just the cyclooxygenase pathway probably results in 
shunting of arachidonic acid metabolism to the lipoxygenase pathway [92] (Fig. 2). 
This shunting would result in increased production of lipoxygenase products and, as 
a consequence, increased lung injury [83,93,94]. A complete understanding of this 
seemingly paradoxical effect of cyclooxygenase inhibitors and the role of lipoxygenase 
pathway products as mediators of hyperoxic lung injury awaits studies in which 
measurements of both prostaglandins and leukotrienes in BAL fluid can be performed 
and the effects of selective inhibitors can be determined. 
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Fig. 2: Arachidonate pathway. 
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ROLE OF PULMONARY SURFACTANT 
The change in lung compliance in animals exposed to high concentrations of 0 2 
suggests involvement of the surfactant system. Although most investigators report that 
surface activity of the material lining the alveoli is reduced by exposure to 0 2 at 
increased partial pressures [61 ,95,96,97], others found normal or increased surface 
activity, even in the presence of severe pulmonary 0 2 intoxication [98]. 
Increases as well as decreases in surfactant-associated protein synthesis and 
decreased rates of incorporation of radiolabeled precursors into surfactant 
phospholipid have been reported [96,99]. There are many possible reasons for such 
inconsistency. One is the large species and age differences in susceptibility to 0 2 
toxicity; another is the intensity of hyperoxia used and the stage at which animals were 
studied. Nevertheless, it appears to be reasonably well established that the surface 
activity of the alveolar lining material is significantly decreased in the lungs of animals 
exposed to hyperoxia until death from pulmonary 0 2 intoxication. Whether the 
reduction of pulmonary surfactant function occurs as a direct toxic effect of 0 2 or as 
a consequence of other adverse effects of pulmonary 0 2 poisoning (for instance, 
inactivation of surfactant by intra-alveolar edema [1 00], remains to be determined. In 
either case, reduced surfactant function contributes to the pathophysiological changes 
found during the terminal stages of 0 2 intoxication (Fig. 3). 
lung hyperoxia 
. ~ 
/ ;~:;~=::'~~ ~ ..... ' neutrophil recruitment -.... -.... ..... "" 
endothelial and epithelial ~ · ·d damage release * mediators of - - - _ercosan.or 
inflammation productron 
~ *lysosomal enzyyes 
~ * orgen free radicals 
endothelial and epithelial 
destruction 
~ 
impaired surfactant system 
~ 
edema 
~ . 
death 
Fig. 3: Summary of events leading to hyperoxic death. 
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TOLERANCE AND FACTORS INFLUENCING TOLERANCE TO PULMONARY 
OXYGEN TOXICITY 
Susceptibility of animals to 0 2-induced lung injury varies widely among species [4], 
which may in part be based on differences in metabolic rate, including the degree of 
cytochrome P-450 inducibility [101]. The response to 0 2 is also age-dependent: 
immature animals are less sensitive to 0 2 toxicity than adult animals [53]. The 
increased threshold of young animals to 0 2 toxicity appears to be correlated with their 
ability to increase concentrations of protective enzymes described above in response 
to exposure to 0 2 [1 02]. 
Several constitutional and environmental factors may also influence tolerance 
to hyperoxia. Among factors best explored experimentally are metabolic alterations, 
diet, administered medications and chemicals, and prior exposure to hyperoxia or 
hypoxia. 
Because hyperoxic damage is dependent on the rate of free-radical production 
by intracellular metabolic processes, factors that increase cell metabolism, such as 
epinephrine [1 03], hyperthermia [1 04], testosterone [1 05] and thyroid hormones [1 06], 
exacerbate 0 2 toxicity in experimental animals and may have similar effects in humans. 
Dexamethasone treatment of rats exposed to hyperoxia also increases 0 2-induced 
injury and decreases survival, but this effect seems to be dependent on the time of 
dexamethasone administration; if given when pulmonary inflammation due to hyperoxia 
is marked, dexamethasone improves survival and decreases lung damage [1 07]. 
Deficiencies of vitamins or trace metals in diets increase the susceptibility of the 
experimental animal to hyperoxia. The adverse effects of vitamin E and A deficiency 
in hyperoxic exposure have been especially well documented [52, 108,1 09]; while 
selenium- or copper-deficient diet also lead to increased mortality of rats under 
hyperoxic conditions [11 0,111]. 
Dietary deficiency of protein in rats potentiates toxicity to exposure to 
hyperoxia due to a lack of sulfur-containing amino acids, which are critical for 
glutathione synthesis [112]. A negative nitrogen balance and deprivation of protein may 
make patients in the intensive care unit more susceptible to 0 2 toxicity. Administration 
of sulfur-containing amino acids may protect against this possible potentiation of lung 
injury. 
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Many compounds used therapeutically are metabolized with the production of 
free-radical intermediates (these may be 0 2-derived) and may worsen 0 2-induced lung 
injury. A prominent example is the glycoprotein antibiotic bleomycin, which is used 
clinically in treatment of squamous-cell and germ-cell carcinomas. In animal models, 
the toxic effects of hyperoxia and bleomycin are synergystic, resulting in more 
extensive lung injury and fibrosis [113]. Exacerbations of recognized or occult 
pulmonary fibrosis may also occur as a result of the therapeutic use of other 
antineoplastic agents (including busulfan, methotrexate, cyclophosphamide) and 
fortified inspired 0 2 concentrations during, for example, anesthesia and the immediate 
postoperative period [114, 115]. The mechanism of bleomycin-induced lung injury 
involves the formation of a DNA-bleomycin-Fe+2 complex that has oxidase-like activity, 
producing a superoxide anion after binding to nuclear DNA [116, 117]. Disulfiram and 
nitrofurantoin are similarly metabolized with intermediate production of superoxide or 
hydroxyl radicals and 0 2 expectedly increases its cytotoxicity [ 44, 118]. Paraquat, a 
herbicide which occasionally causes human poisoning, is also more toxic to lungs 
under hyperoxic conditions [119]. Herbicides initiate plant death in. a variety of ways, 
but in many instances they do so by overtaxing or destroying the protective 
mechanisms which control toxic 0 2 species and free radicals [120]. 
To date there are no studies available on the effects of general anesthesia on 
pulmonary 0 2 toxicity apart from studies in which patients have been described who 
showed an increased susceptibility to 0 2-induced lung injury after the use of fortified 
0 2 concentrations during general anesthesia due to drug treatment or herbicide 
intoxication. This could be due to the fact that, generally, anesthesia procedures are 
too brief to induce pulmonary 0 2 toxicity. 
The rat is capable of responding to 80-85% 0 2 by increasing concentrations 
of SOD and the glutathione-related protective enzymes within 3-5 days of exposure 
[121]. Animals pre-exposed to a sublethal concentration of 0 2 are able to tolerate 
prolonged exposures to 100% 0 2 • Pre-adaptation of adult rats to hypoxia (10% 0 2 for 
7 days) also results in tolerance to 0 2-induced lung injury and is associated with an 
increase in SOD concentration [122]. On the other hand, pre-exposure of rats to 40-
60% 0 2 does not increase protective- enzyme concentrations and decreases tolerance 
to subsequent exposure to 100% 0 2 [123]. These findings suggest that almost lethal 
levels of superoxide radical production or cell damage are required to increase 
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protective-enzyme concentrations by hyperoxia or hypoxia. 
THERAPEUTIC APPROACHES TO PROTECTION FROM PULMONARY OXYGEN 
TOXICITY 
Many animal models of increased 0 2 tolerance have been investigated, but to date no 
clinically useful means of reducing 0 2-induced lung injury in humans exists. Some 
experimental models will be discussed here because therapeutic measures effective 
in preventing or decreasing the effects of 0 2 toxicity, based on the results of these 
animal studies, may be introduced to clinical practice in the near future. 
To this point, the most effective pharmacologic agent described for increasing 
0 2 tolerance in rats is bacterial endotoxin. The protection provided by endotoxin is 
species-specific (rats and lambs develop 0 2 tolerance, but mice and hamsters do not; 
primates have not been tested) [1 09,124, 125]. The mechanism of endotoxin protection 
against hyperoxic injury is not known. The improved tolerance has been associated 
with increases in lung SOD and other antioxidant enzymes during hyperoxic exposure 
[42, 123, 126]. However, the protective effect of endotoxin is blocked by acetylsalicylic 
acid [91] which interferes with prostaglandin metabolism. Although production of 
lipoxygenase metabolites by BAL lavage cells is not inhibited by endotoxin [127], 
inhibition of in vivo free-radical release by lung neutrophils has been proposed as the 
mechanism by which endotoxin protects rats from 0 2 toxicity [128]. Endotoxin 
treatment stimulates the production of at least three potent cytokines: tumor necrosis 
factor jcachectin, interleukin 1, and interferon. All three factors have been implicated 
as playing an important role in endotoxin's protective action; pretreatment of rats with 
either tumor necrosis factor j cachectin and interleukin 1 [129], interferon inducers 
[130], or simply serum of endotoxin-protected rats [131] decreases lung injury and 
mortality in hyperoxia. Endotoxin also protects against hyperoxic injury to porcine 
endothelial cells [132]. It has been suggested that endotoxin protects these cultured 
endothelial cells by prevention of the hyperoxia-induced decrease in plasma membrane 
fluidity [133]. Currently, there is great interest in the attempt to modify the endotoxin 
molecule to produce protective substances which have low inherent toxic action, so-
called endotoxoids [134]. 
Difficulties arise with the therapeutic use of SOD or catalase because they are 
intracellular enzymes with very short half-lives in plasma. There is, therefore, little scope 
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for their use by direct intravenous injection. However, it is possible for these enzymes 
to enter cells if they are administered in liposomes and their plasma half-life may also 
be extended by conjugation with polyethylene glycol. Experimental use of SOD and 
catalase in these forms results in a substantial protection [135, 136,137,138, 139]. 
Polyethylene glycol conjugation with antioxidants may be more effective than liposome 
encapsulation [140]. Delivery of antioxidants conjugated to polyethylene glycol is 
improved and their half-lives prolonged compared with liposome encapsulation. 
Instillation of exogenous surfactant in rabbits exposed to 100% 0 2 for 64 h 
prevents the development of abnormal lung mechanics and alveolar collapse and 
mitigates the degree of lung edema, once animals are returned to room air; at least 
part of this beneficial effect appears to be related to the action of exogenous surfactant 
in preventing an increase in alveolar surface tension [141]. 
The leukotriene synthesis blocker AA861 significantly reduces mortality of rats 
caused by 0 2 toxicity when administered intraperitoneally [89]. AA861 inhibits 
leukotriene 84 production, a chemotactic agent for neutrophils and, thus, AA861 would 
reduce the accumulation of neutrophils in the lung. 
Intact erythrocytes placed in the tracheobronchial tree of hyperoxic rats 
dramatically improves their chances for survival [142]. Lungs from erythrocyte-
protected rats show almost none of the morphologic damage suffered by untreated 
animals. These protective effects of insufflated erythrocytes would be based on their 
recyclable glutathione. An ironic connotation of these experiments is that small 
amounts of spontaneous alveolar hemorrhage, a common feature in respiratory 
distress situations, may actually be beneficial in patients ventilated with 0 2 at high 
inspired tensions. 
Continuous infusion of the sulfhydryl compounds cysteamine or N-
acetylcysteine in rats exposed to 100% 0 2 results in a reduced mortality and lung 
edema caused by hyperoxia [143]. As sulfhydryl compounds are among the most 
important endogenous antioxidant agents, administration of these cell-permeable 
sulfhydryl compounds probably prevents the oxidation of lung nonprotein sulfhydryls 
such as glutathione [144]. 
Desferioxamine is an iron-chelating agent that may prove to have a therapeutic 
role, as ferrous iron is both a potent source of electrons for conversion to the 
superoxide anion and a catalyst in the Fenton reaction. In rats, the administration of 
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desferioxamine provides partial protection against hyperoxic lung damage [145]. 
Pretreatment of rats by inducers of pulmonary cytochrome P-450 results in a 
marked protection against pulmonary 0 2 toxicity. This protection is associated with a 
substantial increase in the components of the pulmonary cytochrome P-450 system, 
its peroxidase activity and an increased response to hyperoxia by lung antioxidant 
enzyme activities [146]. 
Although dietary supplementation of vitamins, proteins and trace metals 
provides only partial protection in animals with a deficiency of these factors, dietary 
supplementation of polyunsaturated fatty acids in newborn rats results in increased 
lung polyunsaturated fatty acid content and improved hyperoxic survival [147]. How 
lung lipid composition works to influence tolerance to pulmonary 0 2 toxicity is not yet 
known. 
CONCLUSION 
The last 25 years have seen major progress in our understanding of the mechanisms 
and pathophysiology of pulmonary 0 2 toxicity and, in particular, the elucidation of the 
role of free radicals. Important problems that remain include methods for early 
detection of hyperoxic damage and the means to augment antioxidant defenses. With 
solution of these problems it should be possible to expand significantly the value and 
indications for the therapeutic use of 0 2 • 
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ABSTRACT 
This study investigated the involvement of substances derived from arachidonic acid 
in the mechanism of endotoxin's protective action against pulmonary oxygen toxicity. 
Eighty-three percent of rats treated with a small dose of endotoxin (1 mgjkg) survived 
exposure to over 95% oxygen for 7 days. In contrast, all control rats exposed to the 
same oxygen concentration died within 3 days. When the endotoxin-treated rats were 
a/so treated with the soluble lysine salt of acetylsalicylic acid (100 mgjkg), 7-day 
survival decreased to 25%. This suggests that prostaglandin metabolism may play an 
important role in the protective action of endotoxin during hyperoxia. 
INTRODUCTION 
Despite the potential dangers of hyperoxia on the lung, administration of above-
ambient oxygen tensions is necessary for treatment of severe hypoxemia caused by 
respiratory failure or acute lung injury. 
Small doses of bacterial endotoxin markedly increase the survival rate of adult 
rats exposed to 98% oxygen for periods that are normally lethal (60-72 h) [1 ,2]. Details 
concerning the mechanism and even the cellular site(s) of endotoxin's action are not 
yet known, but there is evidence that the pulmonary responses after bacterial 
endotoxin administration are due to release of substances derived from arachidonic 
acid [3] and that these responses can be prevented by concurrent treatment with 
various cyclooxygenase inhibitors [4]. We investigated the involvement of arachidonic 
acid derivatives in the mechanism of endotoxin's protective action against pulmonary 
toxicity, by combined treatment with endotoxin and the soluble lysine salt of 
acetylsalicylic acid (L-ASA). 
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METHODS 
Forty-eight male Sprague-Dawley rats (TNO, Rijswijk, NL) weighing 250-300 g and 
maintained on a standard laboratory diet were assigned at random to four different 
treatment groups: an endotoxin group, a control group, an endotoxin with L-ASA 
group, and an L-ASA group. Each group had 12 rats. 
Endotoxin-treated rats were given a single intraperitoneal (ip) injection of 1 
mgjkg endotoxin (Salmonella typhimurium lipopolysaccharide, phenol water extraction: 
Sigma Chemical Co, London, UK) dissolved in normal saline. Control rats received an 
equal volume of ip normal saline. L-ASA treated rats received 100 mgjkg L-ASA 
subcutaneously (sc), 30 min before the ip endotoxin or saline administration, and every 
24 h thereafter. 
Directly after endotoxin or saline administration, half of the rats in each group 
(chosen at random) were exposed to compressed air at 1 atm of pressure, while the 
other half were exposed to 100% oxygen at 1 atm of pressure. Exposures lasted a 
maximum of 7 days and were performed in special airtight cages with an overflow hole; 
each cage contained 12 rats. Oxygen concentration was continuously measured 
(oxygen monitor, Instrumentation Laboratories, Lexington, MA) and was constantly 
higher than 95% in the oxygen-perfused cages. The C02 concentration was held 
constant at a level similar to that of room air (0.033%) by means of a high oxygen flow 
(7 -8 complete gas changes per hour) and by placing containers of soda lime chips in 
the cage. The cage temperature was held constant between 23° and 26°C. Water and 
food were provided ad libitum. The cages were opened once a day for a 10-15 min 
period to facilitate injection, replenishment of food and water, and waste removal. 
Survival was monitored on a daily basis. Changes in duration of survival were reflected 
by a shift of the survival curve to the right or left. We used the Wilcoxon test to 
determine whether such shifts were statistically significant at a level of 0.05. 
RESULTS 
Although the saline-treated rats and the L-ASA-treated rats exposed to 100% oxygen 
all died within 3 days, 83% of the endotoxin-treated rats survived for 7 days (Fig. 1). 
Of the rats treated with endotoxin plus L-ASA, 25% survived 7 days of oxygen 
exposure. By contrast, there were no deaths in identically treated groups exposed to 
compressed air. The survival curve for rats pretreated with endotoxin was significantly 
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(p < 0.01) to the right of the survival curve for saline-treated rats. This prolonged 
survival was partly reversed by concurrent treatment with L-ASA (p < 0.05). 
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Fig. 1: Survival of rats of exposed to over 95% oxygen for 7 days. The 
survival curve for rats pretreated with endotoxin is significantly (p 
< 0.01) to the right of the survival curve for saline-treated rats. This 
prolonged survival was partly reversed by concurrent treatment with L-
ASA (p < 0.05). 
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DISCUSSION 
According to the free-radical theory of oxygen toxicity, exposure to hyperoxia elevates 
the intracellular oxygen concentration and increases the production of highly reactive 
oxygen species such as superoxide anion (02-) and hydrogen peroxide (HP2) [5]. 
The possible relationship between free-radical reactions and the microcirculation stems 
from work revealing the dependency of a patent microcirculation on the continuing 
balanced production of prostaglandin 12 (PG12) [6]. PGI2 , which is produced by blood 
vessel walls, is essential to keep the endothelial surface free of platelets and other 
adhering blood elements. Platelets and lung parenchyma are constantly producing 
thromboxane ~ (T~), a potent vasoconstrictor which has marked pro-aggregating 
and pro-adhering effects on platelets. The continuing synthesis of PGI2 by blood vessel 
walls constantly opposes the effects of T~; this synthesis is inhibited by lipid 
hydroperoxide products of free-radical reactions, but can be stimulated by a single 
dose of endotoxin [7]. Thus, it seems likely that endotoxin protects the pulmonary 
microcirculation from hyperoxic injury [8]. 
We found that repeated administration of L-ASA partly reversed endotoxin-
induced protection. Frank and Roberts [1] also administered a cyclooxygenase 
inhibitor (ip indomethacin) to endotoxin-treated rats exposed to over 95% oxygen 
concentrations, but they did not find any detrimental effect on endotoxin-induced 
protection expressed as survival. Although this discrepancy is difficult to interpret, it 
is possible that the single 3-mgjkg dose of indomethacin was not sufficient to block 
the cyclooxygenase enzyme for the total period of endotoxin-induced activation, 
whereas repeated doses of 100 mgjkg L-ASA inhibited cyclooxygenase throughout 
the exposure to high oxygen concentrations [9]. 
REFERENCES 
1. Frank L, Roberts RJ: Oxygen toxicity: Protection of the lung by the bacterial 
lipopolysaccharide (endotoxin). Toxicol Appl Pharmacol1979; 50: 371. 
2. Frank L, Summerville J, Massaro D: Protection from oxygen toxicity with 
endotoxin: Role of the endogenous antioxidant enzymes of the lung. J Clin 
Invest 1980; 65: 1104. 
40 
3. Coker SJ, Hughes B, Parratt JR, et al: The release of prostanoids during the 
acute pulmonary response to E. coli endotoxin in anaesthetized cats. Br J 
Pharmacol1983; 78: 561. 
4. Parratt JR, Sturgess RM: E coli endotoxin shock in the cat; treatment with 
indomethacin. Br J Pharmacol1975; 53: 485. 
5. Freeman BA, Crapo JD: Hyperoxia increases oxygen radical production in rat 
lungs and lung mitochondria. J Bioi Chem 1981; 256: 10986. 
6. Moncada S, Cryglewski RJ, Buntin J, et al: A lipid peroxide inhibits the enzyme 
in blood vessel microsomes that generates from prostaglandin endoperoxides 
the substance (prostaglandin X) which prevents platelet aggregation. 
Prostaglandins 1976; 12: 715. 
7. VillaS, de Gaetano G, Semeraro N: Increased vascular prostacyclin activity 
in rats after endotoxin administration. Experientia 1981; 37: 494. 
8. Crapo JD, Freeman BA, Barry BE, et al: Mechanisms of hyperoxic injury to 
the pulmonary microcirculation. Physiologist 1983; 26: 170. 
9. Villa S, de Gaetano G: Prostacyclin-like activity in rat vascular tissues. Fast, 
long-lasting inhibition by treatment with lysine acetylsalicylate. Prostaglandins 
1977; 14: 1117. 
41 

CHAPTER 3 
CELLULAR AND EICOSANOID COMPOSITION OF BRONCHOALVEOLAR 
LAVAGE FLUID IN ENDOTOXIN PROTECTION AGAINST PULMONARY 
OXYGEN TOXICITY 
This article has been published before in: Grit Care Med 1989; 17: 247-
250 
43 

CELLULAR AND EICOSANOID COMPOSITION OF BRONCHOALVEOLAR LAVAGE 
FLUID IN ENDOTOXIN PROTECTION AGAINST PULMONARY OXYGEN TOXICITY 
Jan Klein, MD; Frederik J. Zijlstra\ BSc; J. Eric Vincent\ PhD; Reel van Strik2 , PhD; 
Corne JAM. Tak, BSc; Wim P. van Schalwijk3 , BSc 
Departments of Anesthesia, 1Pharmacology, 2Biostatistics and 3Experimental Surgery, 
Erasmus University Rotterdam, The Netherlands 
ABSTRACT 
Endotoxin protects against pulmonary oxygen toxicity in rats, and both prostaglandins 
and polymorphonuclear leukocytes (PMN) are implicated as playing an important role 
in this protective action. In this study, a bronchoalveolar lavage (8AL) technique was 
used to analyze cellular and eicosanoid composition of the lavage fluid of endotoxin-
protected oxygen-exposed rats. The 8AL fluid of the endotoxin-protected oxygen-
exposed rats contained the highest number of PMN, while the 8AL fluid of the 
nonprotected oxygen-exposed rats contained the highest number of macrophages. 
Thus, morbidity due to pulmonary oxygen toxicity was correlated with the number of 
macrophages but not with the number of PMN present in the 8AL fluid. Leukotriene 8"' 
thromboxane 8 21 and prostaglandin E2 levels were significantly higher in the lavage 
fluid of nonprotected oxygen-exposed rats compared to the levels in the lavage fluid 
of air-exposed rats. Eicosanoid levels in the 8AL fluid of endotoxin-protected oxygen-
exposed rats did not differ significantly from the levels found in air-exposed control 
rats. These findings suggest that endotoxin protects against hyperoxia-induced 
changes in eicosanoid metabolism. 
INTRODUCTION 
Prolonged exposure to hyperoxia can cause extensive lung injury in many mammalian 
species. Small doses of endotoxin protect rats from the lung damage and edema of 
oxygen toxicity [1]. We reversed the protective action of endotoxin by concomitant 
administration of the lysine salt of acetyl salicylic acid [2]. This could indicate that 
prostaglandins play an important role in endotoxin protective action. 
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Polymorphonuclear leukocytes (PMN) have been implicated as playing an 
important role in acute lung edema resulting from hyperoxic exposure [3]. Several 
arachidonic acid metabolites (eicosanoids) are thought to have an effect on PMN 
adherence [4] and ability to produce superoxide radicals [5]. More recently, it has 
been suggested that leukotriene 84 (LTB.) mediates the recruitment of PMN in the 
lung and that PMN recruitment contributes to lung injury during hyperoxia [6]. In 
addition to their effect on PMN adherence, chemotaxin, and function, eicosanoids 
may also contribute to the increased vascular permeability found in pulmonary oxygen 
toxicity [7]. In this randomized comparative study, a bronchoalveolar lavage (BAL) was 
performed to determine the number and type of cells and eicosanoid levels in the 
lavage fluid of endotoxin-protected oxygen-exposed rats and control rats, respectively. 
MATERIALS AND METHODS 
Experimental Design 
Male Sprague Dawley rats weighing 200 to 250 g and maintained on a standard 
laboratory diet were treated in randomized blocks according to three different 
treatment regimes: oxygen exposure after endotoxin treatment, oxygen exposure after 
saline pretreatment, and air exposure after saline pretreatment. Each group consisted 
of nine rats. Endotoxin-treated rats were given a single intraperitoneal (ip) injection of 
1 mgjkg endotoxin (Salmonella typhimurium lipopolysaccharide, phenol water 
extraction Sigma Chemical, London, UK) dissolved in normal saline. Saline-treated rats 
received an equal volume of ip normal saline. Directly after endotoxin or saline 
administration, the rats were exposed to air or 100% oxygen at 1 atm of pressure. 
Exposures lasted 48 h and were performed in special airtight cages with an overflow 
hole; each cage contained a maximum of six rats housed in separate compartments. 
Oxygen concentration was measured continuously with an oxygen monitor 
(Instrumentation Laboratories, Lexington, MA) and was constantly >95% in the 
oxygen-perfused cages. The C02 concentration was held constant at a level similar to 
that of room air (0.033%) by means of a high oxygen flow (seven to eight complete 
gas changes per hour) and by placement of soda lime chip containers in the cage. The 
cage temperature was held constant between 23° and 26°C. Water and food were 
provided ad libitum. 
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Blood Sampling 
After exposure for 48 h, the rats were anesthetized with sodium pentobarbital (60 
mgjkg ip). The abdomen was opened and the animals were exsanguinated via a 
puncture of the abdominal aorta. Heparinized blood was collected for estimation of 
Hct and plasma protein content (Biuret method [8]). 
Bronchoalveolar Lavage 
A thoracotomy was performed and the volume of pleural fluid was measured by careful 
suction with a syringe. Total protein content of the pleural effusion fluid was measured 
(Biuret method [8]). After an anterior neck incision, the trachea was cannulated with 
a polyethylene catheter. BAL was performed by infusion of 6-ml aliquots of phosphate-
buffered saline. The procedure was performed five times so that a total volume of 30 
ml was installed and >80% was recovered. After lavage, all aliquots were centrifuged 
at 450 rpm for 10 min. The supernatant fraction was decanted for analysis of the 
eicosanoid and albumin content. The lowest detectable albumin concentration was 0.2 
mgjml (Biorad method [9]). 
Cell Counts 
Amounts of cells present in the lavage fluid were counted by a standard 
hemacytometer. The number of PMN, macrophages and lymphocytes were determined 
from Wright-Giemsa-stained differential counts of centrifuged preparations. 
Assay of Eicosanoids 
The lavage fluid was applied to a column consisting of a Sep-pak C 18 and a silica 
cartridge (Waters Assoc., Etten-Leur, The Netherlands) which had previously been 
washed with 10 ml of absolute ethanol and 10 ml of distilled water. The column was 
rinsed with 2 ml of distilled water and the eicosanoids eluted with 2 ml of absolute 
ethanol. Radioimmunoassay was used to detect LTB4 , 6-keto-prostaglandin F1a (6-
keto-PGF1a), thromboxane B2 (TxBJ and prostaglandin E2 (PGE2) levels. 
Anti-LTB. and standard were obtained from Wellcome Research Laboratories 
(Dartford, UK), anti-6-keto-PGF1a from Seragen (Boston, MA), antisera to TxB2 and 
PGE2 from l'lnstitut Pasteur (Paris, France). Prostaglandin standards were obtained 
from Sigma Chemical. Tritiated antigens were purchased from the Radiochemical 
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Centre of Amersham (Amersham, UK). Cross reactivities for relevant compounds were 
<2% at 50% boundjboundo [10]. 
Statistical Analysis 
Analysis of variance was used to establish proper error variances and to test the 
statistical significance of differences between group means. Student's two-sample t-
test and Spearman rank correlation test were applied in appropriate situations. Level 
of significance was set at p < 0.05. 
RESULTS 
Volume and Protein Content Pleural Effusion Fluid 
All oxygen-exposed saline-treated rats showed pleural effusion with a mean volume 
of 3.8 ± 0.7 (SD) mi. The total protein content of the pleural effusion fluid was 43.3 ± 
0.5 mgjml, which was almost equal to the protein content of plasma (48.0 ± 1.39 
mgjml). In the oxygen-exposed endotoxin-treated group, only one rat showed pleural 
effusion with a volume of 5.5 ml and a total protein content of 41.7 mgjml. None of the 
air-exposed rats showed pleural effusion. 
Hematocrits 
The Hct values in the saline-treated oxygen-exposed group were significantly higher 
than those in the endotoxin-treated and in the air-exposed groups (0.48 ± 0.01% vs 
0.40 ± 0.01% and 0.40 ± 0.01%, respectively). There was a significant correlation 
between the height of the Hct and the volume of pleural effusion fluid. 
Albumin Content Lavage Fluid 
The albumin content of the lavage fluid of the oxygen-exposed saline-treated rats was 
0.48 ± 0.07 mgjml. This was significantly higher than the albumin content in the other 
two groups (median concentration <0.2 mgjml). The albumin content of the lavage 
fluid showed significant correlation with the volume of pleural effusion fluid. 
Cells Counts and Differential 
Considerable differences were found in the total number of cells present in the lung 
lavage fluid (Table 1). The lavage fluid of the oxygen-exposed groups contained the 
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TABLE 1. Difference in cellular composition of lavage fluid 
(mean± SE) 
Treatment Mean(% of 02 Control Endotoxin lavaged cells) + Oz 
Number of Cells 
Air control 431 1125 ± 161 a 1303 ± 586° 
Oz control 1556 177 ± 503 
Endotoxin + Oz 1733 
Number ofPMNs 
Air control 1 (0.2) 248 ± 90° 913 ± 443a 
Oz control 249 (17.5) 664 ± 442 
Endotoxin + 02 913 (63.4) 
Number of Macrophages 
Air control 427 (98.8) 715 ± 148a 93 ± 195 
02 control 1142 (80.5) 622 ± 225a 
Endotoxin + Oz 519 (36.0) 
Number of Lymphocytes 
Air control 4 (0.9) 23 ± 7a 3±4 
Oz control 27 (1.9) 20 ± 7a 
Endotoxin + 02 7 (4.9) 
a = p < 0.05. Total number of cells per lavage: number.lO 4 
TABLE 2. Difference in eicosanoid composition of lavage fluid 
(mean± SE) 
Treatment Mean 02 Control Endotoxin 
+Oz 
LTB4 Level 
Air control 2573 2716 ± 807a 1142 ± 807 
0 2 control 5289 1574 ± 807 
Endotoxin + 02 3714 
PGE2 Level 
Air control 57 30 ± 9a 12 ± 9 
02 control 88 19 ± 9a 
Endotoxin + 02 69 
6-keto-PGF1a Level 
Air control 2428 465 ± 748 743 ± 748 
02 control 1963 278 ± 748 
Endotoxin + 02 1685 
TxB2 Level 
Air control 274 167 ± 66a 9 ± 66 
0 2 control 441 176 ± 66a 
Endotoxin + Oz 265 
a = p < 0.05. All eicosanoid levels are shown pgjlavage fluid. 
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highest number of cells. The lavage fluid of the air-exposed rats contained mainly 
macrophages, while there was an influx of neutrophils in the saline-treated oxygen-
exposed group which increased in the endotoxin-treated oxygen-exposed group. In 
absolute numbers, the lavage fluid of the endotoxin-treated oxygen-exposed group 
contained mostly neutrophils, while the lavage fluid of the saline-treated oxygen-
exposed rats contained mostly macrophages. 
Eicosanoid Content Lavage Fluid 
The eicosanoid levels in the lavage fluid of the endotoxin-protected oxygen-exposed 
rats did not differ significantly from the levels found in the lavage fluid of air-exposed 
controls (Table 2). The lavage fluid of the saline-treated, oxygen-exposed rats 
contained significantly more LTB4 , TxB2 , and PGE2 than the lavage fluid of air-exposed 
rats. There was a clear correlation between the level of 6-keto-PGF1a and TxB2 in all 
three groups. 
Relationship between L TB .. and Number of PMN in Lavage Fluid 
Although there was a significant correlation between the level of LTB4 and the number 
of PMN present in the lavage fluids of the air-exposed group, no correlation could be 
found in the other two groups. 
DISCUSSION 
Although hyperoxic lung injury is well recognized pathologically, its pathogenesis has 
not been fully elucidated. It has been postulated that the source of oxygen-derived 
radicals associated with oxygen toxicity may be the PMN [3]. A close temporal 
association between the appearance of PMN in the lung lavage fluid and death of 
animals exposed to hyperoxia has been reported [11]. Endotoxin protects against 
pulmonary damage due to oxygen toxicity [12]. The albumin content of the lavage fluid 
and the amount of pleural effusion are good indications of the extent of pulmonary 
damage [13]. Although the numbers of neutrophils present in the lavage fluid of the 
endotoxin-protected rats were at least as high as the numbers found in the lavage fluid 
of the nonprotected oxygen-exposed group, eight of nine animals in the endotoxin 
group showed signs of protection (no pleural effusion and a low albumin content of the 
50 
lavage fluid). This could be due to a decreased production of free radicals by PMN in 
the endotoxin-treated rats, as suggested by Berg and Smith [14]. 
The numbers of macrophages in the lavage fluid of the oxygen-exposed saline-
treated group were significantly higher than the numbers found in the endotoxin-
protected, oxygen-exposed group and the air-exposed group. These findings resemble 
the observations of Glass et al. [15], who found that in rats the lethality of oxygen 
exposure correlated with the number of mononuclear cells, but not with the number 
of PMN present in BAL fluid. 
Recently, Taniguchi et al. [6] were able to improve survival of oxygen-exposed 
rats using a leukotriene synthesis blocker. They suggested that L TB4 is responsible for 
the accumulation of PMN in the lung and that this PMN recruitment contributes to 
hyperoxic lung injury. In the air-exposed group, there was a significant correlation 
between the number of neutrophils (although very small) and the concentration of LTB4 
on the lavage fluid. In the other two oxygen-exposed groups, no correlation could be 
found. This could be due to the fact that neutrophils themselves, present in abundancy 
in these two groups, break down L TB to degradation products which could be 
detected in this study, or it could indicate that in these two groups LTB4 is not 
responsible for the attraction of PMN to the lungs. 
Thromboxane ~ (T~) stimulates PMN adherence while prostacyclin (PGIJ 
opposes this effect [4]. We found a clear correlation between the level of the hydration 
product of PGI2 (6-keto-PGF1a) and the level of the hydration product ofT~ (Tx82) in 
each group. The fact that TxB2 levels were significantly higher in the oxygen-exposed 
group could indicate that the leukoadherent effect of T~ dominates in the oxygen-
exposed, saline-treated group. We found the highest concentration of PGE2 in the 
oxygen-exposed, saline-treated group. This could be due to a decreased activity of the 
enzyme prostaglandin dehydrogenase (PGDH) which is responsible for the 
degradation of PGE2• The PGDH activity in lung homogenates from guinea pigs 
exposed in vivo to 100% oxygen was found to be decreased [16]. In perfused rat 
lungs, a decrease in PGE2 inactivation has been correlated with the duration of 
exposure to high oxygen concentrations [17]. PGE2 is reported to inhibit the ability of 
PMN to release LTB4 and oxygen-free radicals [6]. Toxic oxygen metabolites are 
thought to play an important role in pulmonary oxygen toxicity. Reactive oxygen 
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derivatives, including hydrogen peroxide (H20J and superoxide (02l may themselves 
influence arachidonic acid metabolism. H20 2, the predominant dismutation product of 
0 2-, has been shown to stimulate both PGE and prostaglandin F production after its 
degradation to an oxygen-centered radical [18]. Organic hydroperoxides, products of 
oxygen-induced lipid peroxidation of cell membranes, stimulate prostaglandin synthesis 
by accelerating the release of arachidonate from lipid stores [19]. 
We found no significant differences in eicosanoid levels between the air-
exposed and oxygen-exposed endotoxin-treated groups. This could indicate that 
endotoxin protects against hyperoxia-induced changes in eicosanoid metabolism and 
may be explained by either a prevention of the hyperoxia-induced increase in 
eicosanoid production or a protection against hyperoxia-induced inhibition of 
eicosanoid degradation [16]. Similar endotoxin action has been described concerning 
serotonin and norepinephrine degradation [20]. Eicosanoid metabolism may play an 
important role in the protective action of endotoxin during hyperoxia [2]. Further 
studies are needed to elucidate the role of eicosanoids in endotoxin-induced protection 
against pulmonary oxygen toxicity. 
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CHAPTER 4 
ENDOTOXIN PROTECTION AGAINST PULMONARY OXYGEN TOXICITY 
AND ITS REVERSAL BY ACETYL SALICYLIC ACID: ROLE OF 
EICOSANOID PRODUCTION BY BRONCHO-ALVEOLAR LAVAGE CELLS 
This article has been published before in: Agents and Actions 1989; 
26: 246-248 
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ABSTRACT 
Small doses of endotoxin markedly increase the survival rate of adult rats exposed to 
98% oxygen for periods that are normally lethal. The lysine salt of acetyl salicylic acid 
(L-ASA) partially reverses this protective effect of endotoxin. In this pilot study we 
investigated the level of eicosanoid production by broncho-alveolar lavage (BAL) cells 
and found that BAL cells of endotoxin protected rats, present in abundancy, have an 
equal or increased capacity of HHT, 15-HETE, 12-HETE, LTB4 and 5-HETE production. 
These data suggest that production of the lipoxygenase products by BAL cells does 
not seem to play an important role in the pathogenesis of pulmonary oxygen toxicity. 
We did not find any indication for the occurrence of shunting of arachidonic acid 
metabolism to the lipoxygenase pathway as an explanation for the reversal of 
endotoxin's protective action by L-ASA. 
INTRODUCTION 
Endotoxin protects against the development of pulmonary oxygen toxicity in the rat. 
The lysine salt of acetyl salicylic acid (L-ASA) reverses this effect [1]. In a former study 
[2], we found that inhibition of prostaglandin synthesis does not seem to be 
responsible for this reversal. We also found that the broncho-alveolar lavage (BAL) 
fluid of the endotoxin-protected oxygen-exposed rats contained more cells when 
compared with the BAL fluid of the saline-treated oxygen-exposed rats and the saline-
treated oxygen-exposed rats (17.3 x 106 vs 15.6 x 106 and 4.3 x 106 per lavage, 
respectively). 
In this pilot study we measured eicosanoid production by BAL cells after 
calcium ionophore stimulation: 
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1. to test the capacity of eicosanoid production by BAL cells obtained from 
endotoxin-protected oxygen-exposed rats. 
2. to test the hypothesis that the reversal of survival by L-ASA was based on 
shunting of arachidonic acid metabolism to the lipoxygenase pathway. 
METHODS 
Male Sprague Dawley rats weighing 200-250 g and maintained on a standard 
laboratory diet were treated in randomised blocks according to five different treatment 
regimes: air exposure after saline treatment, oxygen exposure after saline treatment, 
oxygen exposure after endotoxin treatment, oxygen exposure after L-ASA treatment 
and oxygen exposure after endotoxin + L-ASA treatment. Each group consisted of 
nine rats. Endotoxin-treated rats were given a single intraperitoneal (i.p.) injection of 
1 mg.kg·' endotoxin (Salmonella typhimurium lipopolysaccharide, phenol water 
extraction: Sigma Chemical Co. London, UK) dissolved in normal saline. Saline-treated 
rats received an equal volume i.p. of normal saline. L-ASA treated rats received 100 
mg.kg·' L-ASA subcutaneously, 30 min before saline administration, and every 24 h 
thereafter. Directly after endotoxin or saline administration, the rats were exposed to 
air, or 100% oxygen at 1 atm of pressure. Exposures were performed in special airtight 
cages. Food and water were provided ad libitum. 
After 48 h of exposure, BAL was performed by infusion of 6 ml aliquots of 
normal saline. The procedure was performed 5 times so that a total volume of 30 ml 
was installed and more than 80% recovered. After lavage, all aliquots were centrifuged 
at 450 x g for 10 min. Numbers of cells were counted by a standard hemacytometer. 
Eicosanoid production by BAL cells was measured after Ca2+ ionophore A23187 
stimulation (final concent. 2 JLM) and a 10 min incubation with 14C-arachidonic acid (1 
JLCi, 58 mCijmmol) and glutathione (final concent. 2 JLM), using a HPLC method. 
RESULTS 
Eicosanoid production by BAL cells is shown in Fig. 1. Other eicosanoids were not 
present in detectable levels. BAL cells of endotoxin-protected oxygen-exposed rats 
produced equal amounts of HHT, 15-HETE and 12-HETE but more (p < 0.05, 
unpaired Student's t-test) L TB4 and 5-HETE when compared with BAL cells of saline-
treated oxygen-exposed rats. 
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Fig. 1: Eicosanoid production by BAL cells (mean ± SD). 
A = Air exposure for 48 h 
0 Oxygen exposure for 48 h 
E Oxygen exposure for 48 h + endotoxin 1 mg.kg-1 i.p. 
C Oxygen exposure for 48 h + endotoxin 1 mg.kg-1 i.p. + 
L-ASA 100 mg.kg-1 24 h-1 s.c. 
L Oxygen exposure for 48 h + L-ASA 100 mg.kg-1 24 h-1 s.c. 
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DISCUSSION 
Although hyperoxic lung injury is well recognised pathologically, its pathogenesis has 
not been fully elucidated. The most effective pharmacologic agent yet described for 
increasing oxygen tolerance in rats is bacterial endotoxin. Lipoxygenase products 
may play a role in the pathogenesis of pulmonary oxygen toxicity, although the source 
of these lipoxygenase products is not yet known [3]. Pulmonary macro phages and 
polymorphonuclear leukocytes (PMN) may also play a role in the pathogenesis of 
hyperoxic damage [4]. A close temporal association between the appearance of PMN 
in the lung lavages and death of animals exposed to hyperoxia has been reported. In 
a former study, we found that PMN were present in abundancy in the lavage fluid of 
endotoxin-protected oxygen-exposed rats [2]. We have measured the capacity of 
eicosanoid production of BAL cells from these endotoxin-protected rats after Ca2+ 
ionophore A23187 stimulation. The results seem to indicate that these BAL cells have 
an equal or increased capacity of 15-HETE, 12-HETE, LTB. and 5-HETE production. 
Assuming that eicosanoid production measured in vitro after Ca2+ ionophore A23187 
stimulation reflects the level of eicosanoid production by BAL cells prior to lavage, the 
data suggest that production of these lipoxygenase products by BAL cells does not 
seem to play an important role in the pathogenesis of pulmonary oxygen toxicity. 
The protective effect of endotoxin is blocked by acetyl salicylic acid. In an 
earlier study we found that inhibition of prostaglandin synthesis does not seem to be 
responsible for this effect [2]. It is possible that blockade of the cyclooxygenase 
pathway results in shunting of arachidonic metabolism to the lipoxygenase pathway 
[5]. Having measured the eicosanoid production by BAL cells after Ca2+ ionophore 
stimulation in vitro, we did not find any indication for the occurrence of shunting of 
arachidonic acid metabolism to the lipoxygenase pathway. However, since there is 
little information on the source of leukotrienes which may play a role in pulmonary 
oxygen toxicity, there is still a possibility that shunting to the lipoxygenase pathway 
does take place in lung tissue. Future studies will concentrate on this aspect. 
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SURFACTANT IN PULMONARY OXYGEN TOXICITY 
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Department of Anesthesia, Erasmus University Rotterdam, The Netherlands. 
INTRODUCTION 
Prolonged continuous exposure to high concentrations of oxygen can lead to 
respiratory failure and death. However, the exact pathogenesis of respiratory failure 
induced by oxygen toxicity has not yet been fully established. This study was designed 
to investigate the role of pulmonary surfactant in the development of respiratory failure 
induced by high concentrations of oxygen. 
METHODS 
Thirty-two Sprague Dawley rats weighing 250-300 g and maintained on a standard 
laboratory diet were used. Twenty-two rats were exposed to I 00% oxygen at I atm of 
pressure in a specially designed polystyrene chamber. Oxygen concentration was 
continuously monitored (Oxygen Monitor, Instrumentation Labs. Lexington, USA) and 
kept at a level above 95% throughout the study. Carbon dioxide concentration was 
held constant at a level similar to room air (0.33%) by means of a high oxygen flow 
and placement of soda lime chip containers in the chamber; temperature in the 
chamber was maintained between 23-26°C. Survival of animals was checked on an 
hourly basis; all oxygen-exposed rats died within 72 h of exposure. 
Directly after death a thoracotomy was performed and the volume of pleural 
effusion was measured. Lungs were dissected, weighed and the trachea was 
cannulated. Pressure-volume (P-V) diagrams were recorded with a maximum 
insufflation pressure of 40 em H20. Following this procedure, broncho-alveolar lavage 
was performed by infusion and gentle aspiration of 9 ml physiological saline; the 
surface tension activity of the lavage fluid was measured with a Wilhelmy balance 
(Biegler, Mauerbach, Austria). 
In a control group of four air-exposed rats, in vivo broncho-alveolar lavage 
was performed according to the method of Lachmann et al [1980], to produce 
surfactant -deficient lungs. Following this procedure, the lungs were ventilated for 15 
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min; the animals then received a lethal intraperitoneal injection of barbiturate. 
Another untreated control group of six air-exposed rats also received a lethal injection 
of barbiturate. Lung weight and surface tension in both control groups were measured 
and P-V diagrams recorded, following the same procedure as for oxygen-exposed 
animals. 
RESULTS 
Pressure-volume diagrams 
The lungs of all oxygen-exposed rats were completely atelectatic. The P-V curves in 
Fig. 1 show that an opening pressure of more than 10 em H20 was needed to open 
the lung. At an insufflation pressure of 40 em H20, the inflated volume was less than 
50% of that in normal lungs (air-exposed, untreated group; Fig. 2). 
The characteristic deflation limb of the P-V curves recorded in oxygen-exposed 
lungs indicates that these lungs are over-stabilized compared with lungs of the air-
exposed group. This was confirmed by the fact that oxygen-exposed lungs did not 
collapse after inflation; they remained completely aerated. 
Lungs in which surfactant deficiency was induced had the same retractive 
forces as oxygen-exposed lungs, with similar opening pressure, but the deflation curve 
was almost linear, an obvious sign of stiffness of the lungs (Fig. 3). 
Surface tension measurements 
No significant difference was found between surface tension activity of lavage fluid 
from oxygen-exposed lungs and air-exposed lungs (Figs. 1, 2 and Table 1). In 
surfactant-deficient, air-exposed lungs, however, surface tension activity was very low 
(Fig. 3 and Table 1). 
Table 1. Surface tension measurements (mean ± SD) 
Air-exposed lungs 
Oxygen-exposed lungs 
Gamma max. mN/m 
51.3 ± 3.2 
51.5 ± 1.6 
Surfactant-deficient lungs 71.6 ± 1.4 
66 
Gamma min. mNjm 
20.7 ± 1.2 
22.9 ± 3.5 
43.4 ± 5.2 
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Fig. 1. Left: Pressure-volume diagram. Right: Surface tension/ surface 
area diagram. Both diagrams show mean values from 22 rats exposed to 
100% oxygen at 1 atm of pressure. 
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Fig. 2. Left: Pressure-volume diagram. Right: Surface tension/surface 
area diagram. Both diagrams show mean values from 6 air-exposed control 
rats. 
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Fig. 3. Left: Pressure-volume diagram. Right: Surface tension/surface 
area diagram. Both diagrams show mean values from 4 rats following lung 
lavage to produce surfactant-deficient lungs. 
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Wet lung measurements 
The wet weight (x ± SD) of oxygen-exposed lungs was slightly higher than that of air-
exposed lungs: 3.05 ± 0.15 gvs 1.9 ± 0.18 g, respectively. Thewetweightofsurfactant-
deficient, air-exposed lungs was 5.8 ± 1.3 g. 
Pleural effusion volume measurements 
In the oxygen-exposed group pleural effusion values (x ± SD) were 12.8 ± 2.6 ml with 
a serum protein content of 4.1 ± 0.2 g%. 
DISCUSSION 
Prolonged exposure to high concentrations of oxygen can lead to death from 
respiratory failure. Interestingly, this study revealed that lung failure induced by oxygen 
exposure is not the primary cause of death. This is substantiated by the following 
findings: 
1. the lavage fluid of oxygen-exposed lungs showed normal surface tension 
activity; 
2. the average wet weight of oxygen-exposed lungs was only slightly higher than 
that of air-exposed lungs; 
3. although normal surface tension activity was measured in oxygen-exposed 
lungs, the P-V curves showed high retractive forces. This might be due to 
changes in anatomical structure, but this idea is not supported by pathological 
examination of oxygen-exposed lungs in other studies [Crapo et al, 1980]. 
Another explanation could be that high retractive forces are induced by 
dysfunction of the pulmonary surfactant system, probably due to an inhibitor 
which is not yet detectable by surface tension measurements in vitro. 
Stabilization of the deflation limb in these lungs can be explained by the 
presence of fluid with high surface tension in the small airways which leads to 
air trapping [Lachmann, 1988]; 
4. the P-V curves of the oxygen-exposed group, compared to controls, clearly 
showed changes in lung mechanics. Nevertheless, we do not assume that 
these changes in lung mechanics are responsible for the respiratory failure 
and ultimate death. Previous studies have demonstrated that guinea pigs with 
similar P-V curves could survive [Lachmann et al, 1980]. 
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Thus, in accordance with Smith et al [1981] we opine that the large amount of pleural 
effusion found in oxygen-exposed rats, resulting in severe compression of the lung, is 
the only possible explanation remaining as the primary cause of death of rats exposed 
to 100%02 • 
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XANTHINE OXIDASE, ITS PREVENTION AND THERAPY BY EXOGENOUS 
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INTRODUCTION 
Free oxygen radicals (FOR) play an important role in a variety of diseases. The 
hypoxanthine-xanthine oxidase system, which generates the superoxide radical, exerts 
a damaging effect on several organs, including the lung [review: Saugstad, 1985]. It 
has been shown that intravenous hypoxanthine in rats breathing 1 00% oxygen can 
cause lung damage, in contrast to hypoxanthine alone or oxygen alone [Saugstad et 
al, 1984a]. Further, it has been shown [Johnson et al, 1981] that the hypoxanthine-
xanthine oxidase system acutely induces increased capillary permeability in the rat 
lung. We have demonstrated that xanthine oxidase (XO) applied to the trachea of 
guinea-pigs induces dramatic changes in lung-thorax compliance, in the course of a 
few minutes, by destroying the functional integrity of the bronchial and alveolar 
surfactant system, probably by formation of FOR. This effect could be partly prevented 
by superoxide dismutase (SOD) which is a superoxide radical scavenger [Saugstad 
et al, 1984b]. The purpose of this study was to investigate whether it is possible to 
influence the functional changes induced by FOR by tracheal instillation of natural 
surfactant (NS). 
MATERIAL AND METHODS 
Preparation and in vivo characterization of surfactant 
The surfactant used in this study was a natural surfactant isolated from adult rabbit 
lungs in basically the same manner as previously described [Metcalfe et al, 1980] but 
with some modifications. In brief, immediately after the animals received a lethal dose 
of pentobarbital sodium, the lungs were dissected, minced and the tissue washed with 
saline (100 ml/20-25 g tissue) for 30 min, filtered and the filtrates centrifuged at 500 g 
at room temperature to remove cell debris. The supernatant was then centrifuged for 
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one hour at 8000 g at 2-4°C. The surfactant phospholipids were extracted from the 
resulting white pellet with chloroform, methanol, ethanol and acetone. The latter 
procedure was repeated at least twice. 
The resulting surface active material was resuspended in saline so that a 
concentration of 60 mg total phospholipidsjml resulted. The activity of this preparation 
was tested in vivo [Lachmann, 1986] in immature rabbit fetuses from day 27 of 
gestation. In these premature rabbits the instilled surfactant increased lung-thorax 
compliance more than eleven-fold. 
Experimental procedure 
The study was performed using young guinea-pigs, weight range 330-390 g. Following 
anesthesia with pentobarbital sodium (60 mgjkg body weight) the animals were 
tracheotomized. After relaxation with pancuronium (2 mgjkg body weight) animals' 
lungs were ventilated in parallel (6 animals simultaneously) with a Servo ventilator 900 
B (Siemens Elema, Solna, Sweden) according to Lachmann [1985]. The respiratory 
rate was 20 per min, peak pressure 15 em H20, inspiratory time 50% and inspiratory 
oxygen concentration 1 00%. 
One unit XO (Sigma Chemical Co. St. Louis, USA) dissolved in 1 ml saline was 
instilled into the trachea of the animals after a ventilation period of 10 min. 
Simultaneous to the application of the fluid, the peak pressure of the ventilator was 
raised to 35 em H20 and positive end-expiratory pressure of 4 em H20; this was 
necessary to keep the animals alive. This working pressure was maintained in all 
animals throughout the study period, except for the few minutes when pressure-volume 
diagrams were recorded. Pressure-volume diagrams were recorded in each animal by 
placing them alternately into a specially constructed pressure-constant body 
plethysmograph connected to a Servo ventilator 900 B. Volume changes were 
recorded with a Fleisch tube connected to the body plethysmograph via a differential 
transducer (Siemens Elema EMT 34) and amplifier (EMT 31), and an integrator unit 
(Siemens Elema Mingograph 81). 
Five groups of animals were studied: 
1) animals receiving 1 unit XO plus, 35-40 min later, 1.5 ml surfactant (n = 7) 
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2) animals receiving 1 unit XO plus, 35-40 min later, 1.5 ml saline (n=8) 
3) animals receiving nothing, only ventilated (n =4) 
4) animals receiving 1 unit XO followed 1-2 min later by 1.0 ml surfactant plus, 
35-40 min later, additional 1.0 ml surfactant (n = 7) 
5) animals receiving 1 unit XO followed 1-2 min later by 1.0 ml saline plus, 
35-40 min later, 1.0 ml surfactant (n=5). 
RESULTS AND DISCUSSION 
Table 1 shows that the decreased lung-thorax compliance after XO instillation could 
be almost completely restored by tracheal instillation of surfactant (Group 1). 
Table 1. Lung-thorax compliance from the deflation curve of the P-V diagrams. 
Initial 
values 
Group 1 (n=7) 100 ± 26% 
XO + 1.5 ml surf. 
35-40 min later 
Group 2 (n=8) 100 ± 16% 
XO + 1.5 ml saline 
35-40 min later 
(X±SD) 
30 min after 
xo 
31 ± 11% 
33 ± 13% 
15 min after surf. 
or saline 
84 ± 19% 
25 ± 8% 
This effect must be related to the surfactant lipids and not to fluid administration since 
the lung-thorax compliance deteriorated further in those animals receiving saline 
(Group 2) instead of surfactant. In earlier investigations we demonstrated that the 
combination of fluid with artificial ventilation itself leads to damage, mainly of the 
bronchial surfactant system, which results in an increased opening pressure without 
significant restrictive lung volume changes, at a pressure of 30 em [Lachmann, 1985]. 
Similarly in this study, one factor of functional disturbance can be attributed to the fluid 
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administration. However, we observed both an increased opening pressure and a 
significant decrease in volume at a pressure of 30-35 em Hp after XO instillation. In 
those healthy animals which were artificially ventilated only (Group 3, n=4) there was 
no effect on lung-thorax compliance (initial values, 1.11 ± 0.23; after 30 min ventilation, 
1.23 ± 0.22; after 45 min ventilation, 1.21 ± 0.14). 
Tracheal instillation of surfactant 1-2 min after XO instillation partly prevents the effect 
of XO instillation (Table 2). One possible explanation for the latter result could be that 
lipid peroxidation by FOR takes place with exogenous surfactant lipids, thus preventing 
peroxidation of the lipids of the surfactant system, which line the alveoli and airways. 
While surfactant replacement partly prevented and restored the functional changes 
after tracheal XO instillation, it can be concluded from the results that FOR, generated 
by the xanthine oxidase system, also destroy the functional integrity of the bronchial 
and alveolar surfactant system. 
Table 2. Lung-thorax compliance from the deflation curve of the P-V diagrams. 
Initial values 
Group 4 (n = 7) 
XO, 2 min later 100 ± 16% 
1 ml surf; 35-40' 
later 1 ml surf. 
Group 5 (n=5) 
XO, 2 min later 
1 ml sal; 35-40' 
later 1 ml surf. 
(X±SD) 
100 ± 13% 
30 min after 
1st instill. 
(surf. or sal.) 
77 ± 21% 
35 ± 17% 
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15 min after 
2nd instill. 
(surf.) 
92 ± 12% 
84 ± 14% 
CONCLUSION 
The general application of radical scavengers in patients who are at risk of developing 
acute respiratory distress syndrome (RDS) might be one important therapeutic 
approach in the future. However, in all cases where one of the primary causes of 
respiratory failure are free oxygen radicals, additional "local" surfactant replacement 
might be an important step for a successful treatment of RDS. 
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SUMMARY AND CONCLUSIONS 
Prolonged exposure to hyperoxia can cause extensive lung injury in many mammalian 
species (Chapter i). 
It has been shown that small doses of endotoxin protect rats from the lung 
damage and edema caused by oxygen toxicity. The protective action of endotoxin was 
reversed by concomitant administration of the lysine salt of acetylsalicylic acid (L-ASA) 
(Chapter 2). This could indicate that prostaglandins play an important role in 
endotoxin's protective action. 
A subsequent study (Chapter 3) on the cellular and eicosanoid composition of 
broncho-alveolar lavage (SAL) fluid in endotoxin protection against pulmonary oxygen 
toxicity, however, indicated not only that in rats morbidity due to pulmonary oxygen 
toxicity is correlated with the number of macrophages and not with the number of 
leukocytes present in SAL fluid, but also that endotoxin protects against hyperoxia-
induced increases in eicosanoid levels in SAL fluid. This makes it unlikely that inhibition 
of prostaglandin synthesis by L-ASA is responsible for the reversal of the protective 
action of endotoxin. 
Blockade of only the cyclooxygenase pathway of arachidonic acid metabolism 
by L-ASA probably results in shunting to the lipoxygenase pathway. Lipoxygenase 
products have potent properties which all are features of hyperoxic injury. Having 
measured eicosanoid production by SAL cells after Ca2+ ionophore stimulation in vitro 
(Chapter 4) no indication for the occurrence of shunting of arachidonic acid 
metabolism to the lipoxygenase pathway was found. Since the formation of 
lipoxygenase products after Ca2 + stimulation by SAL cells of endotoxin protected rats 
was equal (15-HETE, i2-HETE) or increased (LTB4 and 5-HETE) when compared with 
the formation of lipoxygenase products by BAL cells of non-protected oxygen-exposed 
rats, the formation of lipoxygenase products by SAL cells does not seem to play an 
important role in the pathogenesis of pulmonary oxygen toxicity. However, there is little 
information on the source of lipoxygenase products which may play a role in 
pulmonary oxygen toxicity, thus the possibility remains that L-ASA induced shunting 
to the lipoxygenase pathway does take place in lung tissue. 
Investigating the role of surfactant in the development of respiratory failure due 
to oxygen exposure in rats (Chapter 5), we found that in rats, lung failure (including 
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failure of the surfactant system) is not the primary cause of death. 
In guinea-pigs, however, induction of free oxygen radical mediated lung 
damage by tracheal instillation of xanthine oxidase and ventilation with 100% 0 2 
resulted in decreased lung-thorax compliances which could almost completely be 
prevented, as well as restored, by instillation of exogenous surfactant (Chapter 6). This 
could indicate that surfactant replacement might be effective in the prevention and 
treatment of pulmonary oxygen toxicity. 
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SAMENVATTING EN CONCLUSIES 
Langdurige blootstelling aan hoge concentraties zuurstof kan uitgebreide long schade 
veroorzaken bij de meeste zoogdieren (hoofdstuk 1). 
Lage doseringen endotoxinen beschermen de rat tegen longbeschadiging en 
longoedeem veroorzaakt door zuurstof toxiciteit. Deze beschermende werking van 
endotoxine kan teniet gedaan worden door de gelijktijdige toediening van het lysine 
zout van acetyl-salicylzuur (L-ASA) (hoofdstuk 2). Dit zou kunnen betekenen dat 
prostaglandines een belangrijke rol spelen bij de beschermende werking van 
endotoxine. 
Een volgend onderzoek echter, (hoofdstuk 3) naar de cellulaire en eicosanoide 
samenstelling van broncho-alveolaire lavage (BAL) vloeistof bij endotoxine 
bescherming tegen pulmonale zuurstof toxiciteit, toonde niet aileen aan dat de 
morbiditeit van ratten ten gevolge van pulmonale zuurstof toxiciteit gecorreleerd is met 
het aantal macrofagen en niet met het aantal leukocyten aanwezig in BAL vloeistof, 
maar oak dat endotoxine beschermt tegen de door hyperoxie veroorzaakte verhoging 
in eicosanoid spiegels in BAL vloeistof. Dit maakt het onwaarschijnlijk dat remming van 
de prostaglandine synthese door L-ASA verantwoordelijk is voor het teniet doen van 
de beschermende werking van endotoxine. 
Remming van aileen de cylcooxygenase route van het arachidonzuur 
metabolisme door L-ASA resulteert mogelijk in shunting naar de lipoxygenase route. 
Lipoxygenase producten hebben eigenschappen welke een rol zouden kunnen spelen 
bij de pathogenese van pulmonale zuurstof toxiciteit. Bij bepaling van de eicosanoid 
productie door BAL cellen na Ca 2 + ionophoor stimulatie echter, werd geen aanwijzing 
gevonden voor het optreden van een shunt van het arachidonzuur metabolisme naar 
de lipoxygenase route. Omdat de vorming van lipoxygenase producten door BAL 
cellen van de door endotoxine beschermde ratten gelijk (15-HETE, 12-HETE) of grater 
(LTB4 en 5-HETE) was vergeleken met de vorming van lipoxygenase producten door 
BAL cellen van niet beschermde aan zuurstof blootgestelde ratten, lijkt de vorming van 
lipoxygenase produkten door BAL cellen geen belangrijke rol te spelen in de 
pathogenese van pulmonale zuurstof toxiciteit. Daar er weinig bekend is over de 
oorsprong van de lipoxygenase producten welke mogelijk een rol spelen bij pulmonale 
zuurstof toxiciteit, blijft de mogelijkheid bestaan dat door L-ASA veroorzaakte shunting 
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naar de lipoxygenase route plaats vindt in long weefsel. 
Bij onderzoek naar de rol van surfactant bij het ontstaan van respiratoire 
problemen bij ratten blootgesteld aan hoge zuurstof concentraties (hoofdstuk 5), 
vonden wij dat pathofysiologische afwijkingen van de long (waar onder falen van het 
surfactant systeem) niet de primaire oorzaak zijn van de mortaliteit. 
In cavia's daarentegen, resulteerde de inductie van long schade met zuurstof 
radicalen door middel van de intratracheale inspuiting van xanthine oxidase en 
beademing met 1 00% 0 2 in een verminderde long-thorax compliance welke zowel 
voorkomen als teniet gedaan kon worden door de intratracheale inspuiting van 
exogeen surfactant (hoofdstuk 6). Dit zou kunnen betekenen dat de intratracheale 
toediening van surfactant effectief is bij zowel de preventie als de behandeling van 
pulmonale zuurstof toxiciteit. 
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